Skip to main content

Rakovina Therapeutics Inc(RKV-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Rakovina Therapeutics Inc flat on Tuesday (RKV)

Automated Summaries - The Globe and Mail - Tue May 7, 4:01PM CDT

Rakovina Therapeutics Inc opened trading today at $0.09 and closed at $0.09. prices ranged from $0.09 to $0.09.

Shares $verbed percentage_change percent from the previous day's close of $0.09.

Today across North America, the TSX Composite closed 1.42% at 22259.47, the S&P 500 closed 1.03% at 5180.74, the Dow Jones Industrial Average closed 0.46% at 38852.27 and the Nasdaq Composite closed 1.19% at 16349.25.

Rakovina Therapeutics Inc traded under RKV on the Toronto Venture Exchange (TSX-V).

Trading volume was 31,000 on 4 total trades. On average, Rakovina Therapeutics Inc has traded 29,200 shares over the last 5-days and 72,598 year-to-date.

The TSX-V market on the whole today saw 2,888 price advancers against 2,298 declines and 125 unchanged.

During the prior 52 weeks, RKV.VN has traded as high as $0.16 (May 12,2023) and low as $0.01 (February 26,2024). Moreover, the shares have shrunken -33.33 percent in the last 12 months, while this year, they have advanced 5.88%.

Following today's trading, Rakovina Therapeutics Inc has a market capitalization of $6.28 million on a float of 69,830 shares outstanding. Its annual EPS is $-0.04.

Rakovina Therapeutics Inc is a None company headquartered in Vancouver, CAN.

Rakovina Therapeutics Inc is holding an average recommendation of "Strong Sell" from 0.00 analysts according to Zacks. Currently, there are for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe